New York State Common Retirement Fund Vaxcyte, Inc. Transaction History

New York State Common Retirement Fund

$74.6 Billion
Q4 2024

A detailed history of New York State Common Retirement Fund transactions in Vaxcyte, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 47,295 shares of PCVX stock, worth $3.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

47,295

Previous 57,381 17.58%

Holding current value

$3.9 Million

Previous $6.56 Million 40.95%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 31, 2025	SELL	$80.97 - $117.93 $816,663 - $1.19 Million	-10,086 Reduced 17.58%	47,295 $3.87 Million
Q3 2024 Oct 28, 2024	SELL	$70.52 - $117.12 $6,699 - $11,126	-95 Reduced 0.17%	57,381 $6.56 Million
Q2 2024 Jul 31, 2024	BUY	$60.06 - $78.77 $200,600 - $263,091	3,340 Added 6.17%	57,476 $4.34 Million
Q1 2024 May 07, 2024	SELL	$59.79 - $81.05 $27,981 - $37,931	-468 Reduced 0.86%	54,136 $3.7 Million
Q4 2023 Feb 01, 2024	BUY	$45.35 - $63.41 $53,059 - $74,189	1,170 Added 2.19%	54,604 $3.43 Million
Q3 2023 Nov 07, 2023	SELL	$46.0 - $53.1 $1.85 Million - $2.14 Million	-40,243 Reduced 42.96%	53,434 $2.72 Million
Q2 2023 Aug 07, 2023	BUY	$34.66 - $54.07 $1.59 Million - $2.48 Million	45,933 Added 96.21%	93,677 $4.68 Million
Q1 2023 May 02, 2023	SELL	$36.27 - $47.2 $268,688 - $349,657	-7,408 Reduced 13.43%	47,744 $1.79 Million
Q4 2022 Jan 30, 2023	BUY	$20.58 - $47.95 $376,449 - $877,101	18,292 Added 49.63%	55,152 $2.65 Million
Q3 2022 Nov 08, 2022	BUY	$21.69 - $28.53 $3,361 - $4,422	155 Added 0.42%	36,860 $885,000
Q2 2022 Aug 04, 2022	BUY	$17.68 - $26.58 $106,946 - $160,782	6,049 Added 19.73%	36,705 $799,000
Q1 2022 May 05, 2022	BUY	$17.46 - $26.36 $35,391 - $53,431	2,027 Added 7.08%	30,656 $740,000
Q4 2021 Feb 02, 2022	SELL	$19.32 - $26.45 $2,028 - $2,777	-105 Reduced 0.37%	28,629 $681,000
Q3 2021 Nov 02, 2021	SELL	$20.26 - $26.97 $113,820 - $151,517	-5,618 Reduced 16.35%	28,734 $729,000
Q2 2021 Aug 02, 2021	BUY	$16.45 - $24.06 $217,995 - $318,843	13,252 Added 62.81%	34,352 $773,000
Q1 2021 May 11, 2021	BUY	$18.66 - $29.16 $85,836 - $134,136	4,600 Added 27.88%	21,100 $417,000
Q3 2020 Nov 05, 2020	BUY	$26.5 - $55.4 $437,250 - $914,100	16,500 New	16,500 $815,000

Others Institutions Holding PCVX

# of Institutions

346

Shares Held

130M

Call Options Held

534K

Put Options Held

248K

View Full List

About Vaxcyte, Inc.

Ticker PCVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,315,100
Market Cap $4.89B
Description
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...

More about PCVX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Account

New York State Common Retirement Fund Vaxcyte, Inc. Transaction History